To identify cell surface proteins specifically expressed on primitive AML cells, we used an arrayed antibody screening system to determine the expression of 362 different cell surface markers within the primitive CD3−CD19−CD34+CD38low cell population in TP53-mutated AML bone marrow samples and healthy NBM controls (Fig. 1a). Here, TP53 is linked to acute myeloid leukemia.